Polynovo Ltd PNV
Trading Information
- Previous Close Price
- A$2.20
- Day Range
- A$2.08–2.16
- 52-Week Range
- A$1.10–2.52
- Bid/Ask
- A$2.08 / A$2.10
- Market Cap
- A$1.44 Bil
- Volume/Avg
- 1.1 Mil / 1.7 Mil
Key Statistics
- Price/Earnings (Normalized)
- 249.13
- Price/Sales
- 17.47
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Polynovo earns most of its revenue from US sales of its NovoSorb Biodegradable Temporizing Matrix, or NovoSorb BTM. The product is a patented biodegradable synthetic scaffold to support the regeneration of the dermis when lost through surgery, trauma, burns, or other causes of tissue loss. Once the product is applied to a wound, it takes a few weeks for the dermal layer to fully integrate within the polymer scaffold before a clinician can delaminate the outer layer. A small wound would then close either naturally or with a dressing, while a larger wound would close through a split-skin graft or alternative product such as Avita’s RECELL. NovoSorb BTM then slowly degrades to harmless byproducts which are fully absorbed in roughly 18 months.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Growth
- Total Number of Employees
- 8
- Website
- https://www.polynovo.com
Competitors
Valuation
|
Metric
|
PNV
|
AVH
|
RMD
|
|---|---|---|---|
Price/Earnings (Normalized) | 249.13 | — | 29.72 |
Price/Book Value | 20.79 | 5.97 | 6.78 |
Price/Sales | 17.47 | 3.93 | 6.94 |
Price/Cash Flow | — | — | 24.96 |
Price/Earnings
PNV
AVH
RMD
Financial Strength
|
Metric
|
PNV
|
AVH
|
RMD
|
|---|---|---|---|
Quick Ratio | 4.51 | 6.54 | 1.32 |
Current Ratio | 5.01 | 7.25 | 3.04 |
Interest Coverage | −1.25 | −17.57 | 22.63 |
Quick Ratio
PNV
AVH
RMD
Profitability
|
Metric
|
PNV
|
AVH
|
RMD
|
|---|---|---|---|
Return on Assets (Normalized) | 6.00% | −48.66% | 15.75% |
Return on Equity (Normalized) | 8.49% | −77.11% | 24.94% |
Return on Invested Capital (Normalized) | 6.01% | −58.44% | 19.33% |
Return on Assets
PNV
AVH
RMD
Medical Devices Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ABT
| Abbott Laboratories | Xhlbkpcr | Vzwzx | $181.1 Bil | |
SYK
| Stryker Corp | Vpkkftwn | Mpwvl | $127.5 Bil | |
MDT
| Medtronic PLC | Ckwnbljpd | Tgwvynd | $113.7 Bil | |
BSX
| Boston Scientific Corp | Cmhclkyt | Xczfsm | $109.6 Bil | |
EW
| Edwards Lifesciences Corp | Xjksptjtr | Dwykmh | $54.3 Bil | |
DXCM
| DexCom Inc | Wgdzzwnjbl | Wycx | $52.0 Bil | |
PHG
| Koninklijke Philips NV ADR | Yqvbqqyj | Hmqjwh | $26.4 Bil | |
ZBH
| Zimmer Biomet Holdings Inc | Xtmdltmtsj | Mkh | $24.9 Bil | |
ALGN
| Align Technology Inc | Jbbggkvyb | Ykbrnv | $20.6 Bil | |
SNN
| Smith & Nephew PLC ADR | Mkhkrzhmx | Qzqxzv | $11.4 Bil |